Noxopharm Limited (ASX:NOX)
Australia · Delayed Price · Currency is AUD 0.0610
-0.0010 (-1.61%)
Oct 8, 2026, 11:23 AM AEST
Noxopharm Market Cap
Noxopharm has a market cap or net worth of 18.74 million as of October 9, 2026. It is the 40,050th most valuable company in the world and the 1,122nd biggest in Australia. Its market cap has decreased by 27.12% in one year.
Market Cap
18.74M
Enterprise Value
23.02M
Revenue
1.43M
Global Rank
Country Rank
#1,122 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 9, 2016, Noxopharm's market cap has increased from 13.91M to 18.74M, an increase of 34.77%. That is a compound annual growth rate of 2.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 18.74M | -31.04% |
| Dec 31, 2025 | 27.18M | - |
| Dec 31, 2024 | 27.18M | 30.99% |
| Dec 29, 2023 | 20.75M | -51.03% |
| Dec 30, 2022 | 42.37M | -62.82% |
| Dec 31, 2021 | 113.97M | -9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 23.86M |
| Neurotech International | 22.62M |
| Imugene | 20.08M |
| Proteomics International Laboratories | 19.84M |
| Algorae Pharmaceuticals | 18.25M |
| Ceryvyn Therapeutics | 17.78M |
| Patrys | 17.47M |
| Argenica Therapeutics | 16.70M |